• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症伴低钙血症患者,伴发肾脏病。

Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease.

机构信息

Department of Gerontology and Metabolism, Division of Nephrology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.

出版信息

Int Urol Nephrol. 2010 Sep;42(3):835-9. doi: 10.1007/s11255-010-9743-6. Epub 2010 May 7.

DOI:10.1007/s11255-010-9743-6
PMID:20449656
Abstract

Elevated serum parathyroid hormone (PTH) level together with hypocalcemia in chronic kidney disease usually suggests secondary hyperparathyroidism. However, primary hyperparathyroidism should also be considered, especially if concomitant vitamin D deficiency is suspected. We report a case of parathyroid adenoma associated with hypocalcemia and metabolic bone disease in a patient presenting with kidney disorder. The patient was successfully treated by parathyroidectomy that was preceded and followed by intensive calcium and vitamin D supplementation.

摘要

血清甲状旁腺激素(PTH)水平升高伴慢性肾脏病低钙血症通常提示为继发性甲状旁腺功能亢进症。然而,也应考虑原发性甲状旁腺功能亢进症,尤其是在怀疑同时存在维生素 D 缺乏的情况下。我们报告了一例甲状旁腺腺瘤相关的低钙血症和代谢性骨病的病例,该患者因肾脏疾病就诊。甲状旁腺切除术治疗该患者获得成功,术后进行了积极的钙和维生素 D 补充。

相似文献

1
Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease.原发性甲状旁腺功能亢进症伴低钙血症患者,伴发肾脏病。
Int Urol Nephrol. 2010 Sep;42(3):835-9. doi: 10.1007/s11255-010-9743-6. Epub 2010 May 7.
2
Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.25-羟维生素D缺乏对原发性甲状旁腺功能亢进患者围手术期甲状旁腺激素动力学及结果的影响。
Surgery. 2007 Dec;142(6):1022-6. doi: 10.1016/j.surg.2007.09.026.
3
Recovery from metabolic bone disease in a girl with vitamin D deficiency rickets associated with primary hyperparathyroidism.一名患有与原发性甲状旁腺功能亢进相关的维生素D缺乏性佝偻病的女孩代谢性骨病的康复情况。
J Pediatr Endocrinol Metab. 1997 Mar-Apr;10(2):237-41. doi: 10.1515/jpem.1997.10.2.237.
4
25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.25-羟基维生素D缺乏是微创甲状旁腺切除术后发生术后低钙血症症状和继发性甲状旁腺功能亢进的危险因素。
Surgery. 2005 Dec;138(6):1018-25; discussion 1025-6. doi: 10.1016/j.surg.2005.09.018.
5
Should vitamin D deficiency be corrected before parathyroidectomy?甲状旁腺切除术前是否应纠正维生素D缺乏?
J Surg Res. 2016 Jul;204(1):94-100. doi: 10.1016/j.jss.2016.04.022. Epub 2016 Apr 22.
6
Persistent hypocalcemia with elevated parathyroid hormone levels after long-term primary hyperparathyroidism: report of a case.长期原发性甲状旁腺功能亢进症后持续低钙血症伴甲状旁腺激素水平升高:一例报告
Surg Today. 2000;30(11):1008-11. doi: 10.1007/s005950070022.
7
Parathyroid adenoma with coeliac disease: primary or quaternary hyperparathyroidism?甲状旁腺腺瘤合并乳糜泻:原发性还是继发性甲状旁腺功能亢进症?
Endokrynol Pol. 2012;63(1):56-8.
8
Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective.甲状旁腺激素及其分泌亢进对骨骼的影响:临床视角。
Curr Osteoporos Rep. 2020 Jun;18(3):103-114. doi: 10.1007/s11914-020-00574-7.
9
[Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].[原发性甲状旁腺功能亢进症。根治性甲状旁腺切除术后血钙正常的高甲状旁腺素血症]
Chirurg. 2010 May;81(5):447-53. doi: 10.1007/s00104-009-1717-9.
10
Hypocalcemia due to spontaneous infarction of parathyroid adenoma and osteomalacia in a patient with primary hyperparathyroidism.原发性甲状旁腺功能亢进患者因甲状旁腺腺瘤自发性梗死导致低钙血症和骨软化症。
Endocr J. 1998 Oct;45(5):617-23. doi: 10.1507/endocrj.45.617.

引用本文的文献

1
Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism.钙负荷试验在不同类型甲状旁腺功能亢进症鉴别诊断中的临床价值
Int J Clin Exp Med. 2014 Nov 25;7(12):5445-52. eCollection 2014.

本文引用的文献

1
Hyperparathyroidism.甲状旁腺功能亢进症。
Lancet. 2009 Jul 11;374(9684):145-58. doi: 10.1016/S0140-6736(09)60507-9.
2
Safety of bisphosphonates in the treatment of osteoporosis.双膦酸盐类药物治疗骨质疏松症的安全性。
Am J Med. 2009 Feb;122(2 Suppl):S22-32. doi: 10.1016/j.amjmed.2008.12.004.
3
Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations.比较透析前和骨质疏松人群中钙二醇不足的患病率。
Int Urol Nephrol. 2009 Dec;41(4):983-8. doi: 10.1007/s11255-008-9509-6. Epub 2008 Dec 5.
4
Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.慢性肾脏病中的双膦酸盐;平衡对骨骼和软组织的潜在益处与不良反应
Clin J Am Soc Nephrol. 2009 Jan;4(1):221-33. doi: 10.2215/CJN.02550508. Epub 2008 Nov 5.
5
Vitamin D levels and early mortality among incident hemodialysis patients.新进入血液透析患者的维生素D水平与早期死亡率
Kidney Int. 2007 Oct;72(8):1004-13. doi: 10.1038/sj.ki.5002451. Epub 2007 Aug 8.
6
Vitamin D deficiency.维生素D缺乏症
N Engl J Med. 2007 Jul 19;357(3):266-81. doi: 10.1056/NEJMra070553.
7
Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.血钙正常的原发性甲状旁腺功能亢进症:一种新临床表型的进一步特征描述
J Clin Endocrinol Metab. 2007 Aug;92(8):3001-5. doi: 10.1210/jc.2006-2802. Epub 2007 May 29.
8
Molecular mechanisms of action of bisphosphonates: current status.双膦酸盐的分子作用机制:现状
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6222s-6230s. doi: 10.1158/1078-0432.CCR-06-0843.
9
25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance.慢性肾脏病患者及透析患者的25(OH)维生素D3:重新认识其重要性
Int Urol Nephrol. 2006;38(2):323-9. doi: 10.1007/s11255-006-0081-7.
10
Evaluation of different bone markers in hemodialyzed patients.血液透析患者不同骨标志物的评估
Clin Chim Acta. 2006 Sep;371(1-2):107-11. doi: 10.1016/j.cca.2006.02.029. Epub 2006 Mar 2.